AI takes on tumor contouring: can it match the experts?

NCT ID NCT06546592

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study compares two ways of outlining tumors for breast cancer radiation: one done entirely by hand by a doctor, and one where artificial intelligence (AI) helps create the outline. The goal is to see if AI-assisted contouring is just as good and whether it saves time. About 444 breast cancer patients will take part across multiple hospitals.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
AI-assisted contouring software (device)
What this could lead to
If successful, this could show that AI can help radiation oncologists contour tumors faster and with similar quality, potentially improving efficiency in radiotherapy planning.
What could go wrong
This is a phase II trial, so results are still preliminary. The AI software is custom-built and may not work as well in other hospitals or for other cancer types. There is also a risk that AI-assisted contours may be less accurate than manual ones.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARTIFICIAL INTELLIGENCE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Central West Cancer Centre

    RECRUITING

    Orange, New South Wales, 2800, Australia

  • Department of Radiation Oncology, Royal North Shore Hospital

    RECRUITING

    St Leonards, New South Wales, 2065, Australia

  • Western Cancer Centre Dubbo

    RECRUITING

    Dubbo, New South Wales, 2830, Australia

More trials for these conditions

Other studies related to the condition(s) this trial covers.